Transaortic extended septal myectomy is the most reliable method for septal reduction for symptomatic patients with obstructive hypertrophic cardiomyopathy. In addition, surgical management of nonobstructive hypertrophic cardiomyopathy is possible for selected patients with diastolic heart failure and small left ventricular end-diastolic cavity dimensions. These procedures, however, are performed infrequently in many centers, and trainees may not be exposed to the preoperative evaluation and intraoperative management of patients with hypertrophic cardiomyopathy. In this paper, we review what we believe are the central features for creating a successful program for septal myectomy and detail our strategies to optimize instruction in these techniques for residents and fellows.
McKennaWJJudgeDP. Epidemiology of the inherited cardiomyopathies. Nat Rev Cardiol2021; 18: 22–36.
2.
MaronMSOlivottoIZenovichAG, et al.Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation2006; 114: 2232–2239.
3.
MaronBJDearaniJAOmmenSR, et al.Low operative mortality achieved With surgical septal myectomy: role of dedicated hypertrophic cardiomyopathy centers in the management of dynamic subaortic obstruction. J Am Coll Cardiol2015; 66: 1307–1308.
NguyenASchaffHVHangD, et al.Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a propensity score-matched cohort. J Thorac Cardiovasc Surg2019; 157: 306–315. e3.
6.
ValetiUSNishimuraRAHolmesDR, et al.Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol2007; 49: 350–357.
7.
ten CateFJSolimanOIIMichelsM, et al.Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution. Circ Heart Fail2010; 3: 362–369.
8.
CrileyJMLewisKBWhiteRIJr, et al. Pressure gradients without obstruction. A new concept of ‘hypertrophic subaortic stenosis’. Circulation1965; 32: 881–887.
9.
CrileyJMSiegelRJ. Obstruction is unimportant in the pathophysiology of hypertrophic cardiomyopathy. Postgrad Med J1986; 62: 515–529.
10.
MaronBJMaronMSWigleED, et al.The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy. J Am Coll Cardiol2009; 54: 191–200.
11.
NguyenASchaffHVOmmenSR, et al. Late health status of patients undergoing myectomy for obstructive hypertrophic cardiomyopathy. Ann Thorac Surg.2021; 111: 1867–1875. DOI: 10.1016/j.athoracsur.2020.09.011.
12.
CuiHSchaffHVAbelMD, et al.Left ventricular ejection hemodynamics before and after relief of outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy and valvular aortic stenosis. J Thorac Cardiovasc Surg2020; 159: 844–852. e1.
13.
Tower-RaderAFuriasseNPuthumanaJJ, et al.Effects of septal myectomy on left ventricular diastolic function and left atrial volume in patients with hypertrophic cardiomyopathy. Am J Cardiol2014; 114: 1568–1572.
14.
AyoubCGeskeJBLarsenCM, et al.Comparison of valsalva maneuver, amyl nitrite, and exercise echocardiography to demonstrate latent left ventricular outflow obstruction in hypertrophic cardiomyopathy. Am J Cardiol.2017; 120: 2265–2271.
15.
ElesberANishimuraRARihalCS, et al.Jr.Utility of isoproterenol to provoke outflow tract gradients in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2008; 101: 516–520..
16.
CuiHSchaffHVNishimuraRA, et al. Latent outflow tract obstruction in hypertrophic cardiomyopathy: clinical characteristics and outcomes of septal myectomy. J Thorac Cardiovasc Surg. 2020. DOI: 10.1016/j.jtcvs.2020.12.016.
17.
NishimuraRAOmmenSR. Hypertrophic cardiomyopathy: the search for obstruction. Circulation2006; 114: 2200–2202.
18.
SchaffHVBrownMLDearaniJA, et al.Apical myectomy: a new surgical technique for management of severely symptomatic patients with apical hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg2010; 139: 634–640.
19.
NguyenASchaffHVNishimuraRA, et al. Apical myectomy for patients with hypertrophic cardiomyopathy and advanced heart failure. J Thorac Cardiovasc Surg. 2020; 159: 145–152. DOI: 10.1016/j.jtcvs.2019.03.088.
20.
HangDSchaffHVOmmenSR, et al. Combined transaortic and transapical approach to septal myectomy in patients with complex hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2018; 155: 2096–2102. DOI: 10.1016/j.jtcvs.2017.10.054.
21.
SunDSchaffHVNishimuraRA, et al. Transapical septal myectomy for hypertrophic cardiomyopathy with midventricular obstruction. Ann Thorac Surg. 2021; 111: 836–844. DOI: 10.1016/j.athoracsur.2020.05.182.
22.
BinderJAttenhofer JostCHKlarichKW, et al.Apical hypertrophic cardiomyopathy: prevalence and correlates of apical outpouching. J Am Soc Echocardiogr2011; 24: 775–781.
23.
RowinEJMaronBJChokshiA, et al. Left ventricular apical aneurysm in hypertrophic cardiomyopathy as a risk factor for sudden death at any age. Pacing Clin Electrophysiol. 2018. DOI: 10.1111/pace.13413.
24.
NguyenASchaffHV. Electrical storms in patients with apical aneurysms and hypertrophic cardiomyopathy with midventricular obstruction: a case series. J Thorac Cardiovasc Surg2017; 154: e101–e103.
25.
OmmenSRParkSHClickRL, et al.Impact of intraoperative transesophageal echocardiography in the surgical management of hypertrophic cardiomyopathy. Am J Cardiol2002; 90: 1022–1024.
26.
ThadenJJMaloufJFRehfeldtKH, et al. Adult intraoperative echocardiography: a comprehensive review of current practice. J Am Soc Echocardiogr. 2020; 33: 735–755 e11. DOI: 10.1016/j.echo.2020.01.012.
27.
AshikhminaEASchaffHVOmmenSR, et al.Intraoperative direct measurement of left ventricular outflow tract gradients to guide surgical myectomy for hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg2011; 142: 53–59.
28.
CarvalhoJLAshikhminaEAbelMD, et al. Hypertrophic obstructive cardiomyopathy: discrepancy between hemodynamic measurements in the cardiac laboratory and operating room is to be expected. J Cardiothorac Vasc Anesth. 2021. Advance online publication. DOI: 10.1053/j.jvca.2021.05.041.
SaidSMSchaffHVAbelMD, et al.Transapical approach for apical myectomy and relief of midventricular obstruction in hypertrophic cardiomyopathy. J Card Surg2012; 27: 443–448.
HermsenJLBurkeTMSeslarSP, et al.Scan, plan, print, practice, perform: development and use of a patient-specific 3-dimensional printed model in adult cardiac surgery. J Thorac Cardiovasc Surg2017; 153: 132–140.
34.
TakayamaHYuSNSorabellaR, et al.Virtual septal myectomy for preoperative planning in hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg2019; 158: 455–463.
35.
MenonPGRaoPVAdhyapakSM, et al.Virtual surgical myectomy as a planning tool for obstructive hypertrophic cardiomyopathy. J Cardiovasc Magn Reson2016; 18: P46.
36.
AndrushchukUAdzintsouVNevyglasA, et al.Virtual and real septal myectomy using 3-dimensional printed models. Interact Cardiovasc Thorac Surg2018; 26: 881–882.
37.
AndrushchukUAdzintsouVNiavyhlasA, et al.Early results of optimal septal myectomy using 3-dimensional printed models. Kardiochir Torakochirurgia Pol2019; 16: 74–80.
38.
ChoYHQuintanaESchaffHV, et al.Residual and recurrent gradients after septal myectomy for hypertrophic cardiomyopathy-mechanisms of obstruction and outcomes of reoperation. J Thorac Cardiovasc Surg2014; 148: 909–915. discussion 915–6.
39.
CuiHNguyenASchaffHV. The brockenbrough-braunwald-morrow sign. J Thorac Cardiovasc Surg2018; 156: 1614–1615.
40.
BirkmeyerJDStukelTASiewersAE, et al.Surgeon volume and operative mortality in the United States. N Engl J Med2003; 349: 2117–2127.
41.
WenH-CTangC-HLinH-C, et al.Association between surgeon and hospital volume in coronary artery bypass graft surgery outcomes: a population-based study. Ann Thorac Surg2006; 81: 835–842.
42.
BadhwarVVemulapalliSMackMA, et al. Volume-Outcome association of mitral valve surgery in the United States. JAMA Cardiol. 2020; 5: 1092–1101. DOI: 10.1001/jamacardio.2020.2221.
43.
KimLKSwaminathanRVLooserP, et al.Hospital volume outcomes after septal myectomy and alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: US nationwide inpatient database, 2003–2011. JAMA Cardiol2016; 1: 324–332.
44.
LiHDengLLiuH, et al.Influence of operator volume on early outcomes of septal myectomy for isolated hypertrophic obstructive cardiomyopathy. J Thorac Dis2021; 13: 1090–1099.
45.
OmmenSRMitalSBurkeMA, et al. 2020AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol2020; 76: 3022–3055.
